GlassScriptPhysician profile
Thomas C Baldacchino
NPI 1720057631
$1,696.77
in general payments reported to CMS, 2019-2025
18 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $26.50 · 2022: $185 · 2023: $552 · 2024: $236 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $350.12 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $208.69 | 2023-2025 | |
| Abiomed | $202.22 | 2019 | |
| Heartflow, INC. | $179.50 | 2022-2023 | Ffrct |
| Pfizer INC. | $157.77 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.60 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $109.13 | 2023 | Xarelto |
| Boston Scientific Corporation | $82.42 | 2025 | Farapulse, Watchman Flx |
| Irhythm Technologies, INC. | $45.14 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $44.18 | 2024 | Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $36.64 | 2019-2022 | |
| Abbott Laboratories | $25.65 | 2023 | Cardiomems |
| Impulse Dynamics (USA) INC. | $25.45 | 2023 | Optimizer |
| Inspire Medical Systems, INC. | $24.32 | 2024 | Inspire |
| Siemens Medical Solutions USA, INC. | $21.95 | 2024 | Artis Icono Floor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.49 | 2025 | Jardiance |
| Cardiva Medical, INC. | $14.14 | 2020 | |
| Teleflex LLC | $12.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Baldacchino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.